Orooji; Mahdi

Patent Applications and Registrations

Patent applications and USPTO patent grants for Orooji; Mahdi.The latest application filed is for "methods and apparatus for predicting benefit from immunotherapy using tumoral and peritumoral radiomic features".

Company Profile

6.8.8

Orooji; Mahdi - Cleveland OH

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Methods and apparatus for predicting benefit from immunotherapy using tumoral and peritumoral radiomic features Grant 10,950,351 - Madabhushi , et al. March 16, 2	2021-03-16
Characterizing lung nodule risk with quantitative nodule and perinodular radiomics Grant 10,470,734 - Madabhushi , et al. Nov	2019-11-12
Predicting response to pemetrexed chemotherapy in non-small cell lung cancer (NSCLC) with baseline computed tomography (CT) shape and texture features Grant 10,458,895 - Madabhushi , et al. Oc	2019-10-29
Decision support for disease characterization and treatment response with disease and peri-disease radiomics Grant 10,398,399 - Madabhushi , et al. Sep	2019-09-03
Computerized analysis of computed tomography (CT) imagery to quantify tumor infiltrating lymphocytes (TILs) in non-small cell lung cancer (NSCLC) Grant 10,346,975 - Madabhushi , et al. July 9, 2	2019-07-09
Methods And Apparatus For Predicting Benefit From Immunotherapy Using Tumoral And Peritumoral Radiomic Features App 20190156954 - Madabhushi; Anant ; et al.	2019-05-23
Characterizing Lung Nodule Risk With Quantitative Nodule And Perinodular Radiomics App 20180353149 - Madabhushi; Anant ; et al.	2018-12-13
Characterizing disease and treatment response with quantitative vessel tortuosity radiomics Grant 10,064,594 - Madabhushi , et al. September 4, 2	2018-09-04
Decision Support For Disease Characterization And Treatment Response With Disease And Peri-disease Radiomics App 20180214111 - Madabhushi; Anant ; et al.	2018-08-02
Decision support for disease characterization and treatment response with disease and peri-disease radiomics Grant 10,004,471 - Madabhushi , et al. June 26, 2	2018-06-26
Computerized Analysis Of Computed Tomography (ct) Imagery To Quantify Tumor Infiltrating Lymphocytes (tils) In Non-small Cell Lung Cancer (nsclc) App 20170352157 - Madabhushi; Anant ; et al.	2017-12-07
Predicting Response To Pemetrexed Chemotherapy In Non-small Cell Lung Cancer (nsclc) With Baseline Computed Tomography (ct) Shape And Texture Features App 20170351939 - Madabhushi; Anant ; et al.	2017-12-07
Textural analysis of lung nodules Grant 9,595,103 - Madabhushi , et al. March 14, 2	2017-03-14
Characterizing Disease And Treatment Response With Quantitative Vessel Tortuosity Radiomics App 20170035381 - Madabhushi; Anant ; et al.	2017-02-09
Decision Support For Disease Characterization And Treatment Response With Disease And Peri-disease Radiomics App 20170039737 - Madabhushi; Anant ; et al.	2017-02-09
Textural Analysis of Lung Nodules App 20160155225 - Madabhushi; Anant ; et al.	2016-06-02

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.